全文获取类型
收费全文 | 15283篇 |
免费 | 1064篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 141篇 |
儿科学 | 414篇 |
妇产科学 | 283篇 |
基础医学 | 2070篇 |
口腔科学 | 444篇 |
临床医学 | 1633篇 |
内科学 | 3347篇 |
皮肤病学 | 344篇 |
神经病学 | 1599篇 |
特种医学 | 614篇 |
外国民族医学 | 1篇 |
外科学 | 2381篇 |
综合类 | 73篇 |
一般理论 | 4篇 |
预防医学 | 741篇 |
眼科学 | 325篇 |
药学 | 948篇 |
1篇 | |
中国医学 | 51篇 |
肿瘤学 | 991篇 |
出版年
2022年 | 87篇 |
2021年 | 210篇 |
2020年 | 160篇 |
2019年 | 189篇 |
2018年 | 229篇 |
2017年 | 220篇 |
2016年 | 285篇 |
2015年 | 293篇 |
2014年 | 364篇 |
2013年 | 491篇 |
2012年 | 808篇 |
2011年 | 881篇 |
2010年 | 540篇 |
2009年 | 578篇 |
2008年 | 872篇 |
2007年 | 972篇 |
2006年 | 936篇 |
2005年 | 1000篇 |
2004年 | 941篇 |
2003年 | 949篇 |
2002年 | 919篇 |
2001年 | 371篇 |
2000年 | 365篇 |
1999年 | 344篇 |
1998年 | 231篇 |
1997年 | 184篇 |
1996年 | 168篇 |
1995年 | 154篇 |
1994年 | 123篇 |
1993年 | 98篇 |
1992年 | 161篇 |
1991年 | 171篇 |
1990年 | 147篇 |
1989年 | 163篇 |
1988年 | 112篇 |
1987年 | 119篇 |
1986年 | 123篇 |
1985年 | 100篇 |
1984年 | 118篇 |
1983年 | 86篇 |
1982年 | 62篇 |
1981年 | 55篇 |
1980年 | 60篇 |
1979年 | 87篇 |
1978年 | 71篇 |
1977年 | 51篇 |
1976年 | 58篇 |
1974年 | 61篇 |
1973年 | 50篇 |
1972年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Die Anaesthesiologie - Eine junge Patientin erleidet während der Anlage einer axillären Plexusblockade einen generalisierten Krampfanfall. Die Mechanismen, im Wesentlichen die vermutlich... 相似文献
3.
4.
Clinical Epileptology - Der plötzliche unerwartete Tod stellt eine seltene, aber schwerwiegende Komplikation für Epilepsiepatienten dar. Das Risiko hierfür ist u. a. nachts und... 相似文献
5.
Manuel Steiner Andishe Attarbaschi Margit K nig Helmut Gadner Oskar A. Haas Georg Mann 《Pediatric hematology and oncology》2004,22(1):11-16
Constitutional trisomy 21 is the most prominent predisposing factor to childhood leukemia, whereas the t(12;21)(p13;q22) with its molecular genetic counterpart, the TEL/AML1 fusion gene, is the most common acquired chromosomal rearrangement in childhood B-cell precursor (BCP) acute lymphoblastic leukemia (ALL). Thus, it was somewhat surprising that according to the currently available literature the incidence of TEL/AML1+ BCP ALL is extremely low in patients with Down syndrome (DS). To further investigate this issue in a population-based fashion, the authors retrospectively assessed the number of DS patients with a TEL/AML1+ ALL in two consecutive Austrian ALL multicenter trials. Accordingly, they were able to analyze 8 of 10 individuals with DS and a BCP ALL, including 2 who suffered from a TEL/AML1+ leukemia. Based on this observation we concluded that individuals with a constitutional trisomy 21 may have the similar likelihood to develop a TEL/AML1+ leukemia as BCP ALL patients without this specific predisposing factor. 相似文献
6.
Lei Li Jürgen Bruns Reinhard E. Friedrich Rainer Schmelzle 《European journal of plastic surgery》2006,29(2):93-96
Adamantinoma of long bones is one of the rarest of malignant bone tumors; it is commonly located in the middle or lower third of the diaphysis of the tibia. A case with multiple occurrences affecting both the tibia and fibula is presented. En bloc resection with wide operative margins was performed, and a large tibial defect of 23 cm was effectively bridged by a revascularized free fibular flap. At 13 months follow-up, there was no sign of local recurrence or metastasis, and the patient was mobile. 相似文献
7.
Jan M?schwitzer Rainer H Müller 《European journal of pharmaceutics and biopharmaceutics》2006,62(3):282-287
High pressure homogenization can be employed to produce drug nanocrystals with a number of advantages, like improved solubility behaviors, better drug targeting or even increased mucoadhesiveness. To obtain a controlled drug delivery system it is necessary to transform the resulting nanosuspension into a solid dosage form. The present study shows the feasibility to use a mucoadhesive nanosuspension of poorly soluble hydrocortisone acetate produced by high pressure homogenization as layering dispersion in a fluidized bed process, followed by the application of an enteric coating to achieve a controlled drug release. To point out the advantages of drug nanocrystals the new fomulation was compared with a formulation containing micronized drug. Both formulations were characterized with regard to their particle size and crystallinity by using laser diffractometry, photon correlation spectroscopy and X-ray diffraction. The pellet morphology was characterized by using the environmental scanning electron microscopy (ESEM). In the in vitro dissolution tests an accelerated dissolution velocity and an increased drug release could be shown for the pellets containing drug nanocrystals. 相似文献
8.
9.
10.